• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.利用CLIP评分预测肝细胞癌患者切除术后的复发及预后
World J Gastroenterol. 2002 Apr;8(2):237-42. doi: 10.3748/wjg.v8.i2.237.
2
[Prognostic value of CLIP score system for patients with resection of hepatocellular carcinoma].[CLIP评分系统对肝细胞癌切除患者的预后价值]
Zhonghua Wai Ke Za Zhi. 2002 May;40(5):321-5.
3
Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.使用多变量分析对不同分期系统预测的肝细胞癌患者生存率的比较研究。
Eur J Surg Oncol. 2005 Oct;31(8):882-90. doi: 10.1016/j.ejso.2005.04.016.
4
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.CLIP、奥田、TNM和JIS分期系统对接受手术的肝细胞癌患者的预测价值评估。
J Gastroenterol Hepatol. 2005 May;20(5):765-71. doi: 10.1111/j.1440-1746.2005.03746.x.
5
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
6
Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.消融后去γ-羧基凝血酶原水平可预测乙型肝炎相关肝细胞癌的预后。
Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18.
7
Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.预后列线图对根治性切除术后无门静脉肿瘤血栓形成的肝细胞癌患者的生存情况进行分层。
Oncologist. 2017 May;22(5):561-569. doi: 10.1634/theoncologist.2016-0231. Epub 2017 Apr 24.
8
Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.术前基于炎症的标志物可预测根治性肝切除术后肝细胞癌的早期和晚期复发。
Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):266-74. doi: 10.1016/s1499-3872(16)60094-2.
9
Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.使用异常凝血酶原(PIVKA-II)改良的CLIP评分系统用于评估肝细胞癌肝切除术后的预后
Eur J Surg Oncol. 2003 Nov;29(9):735-42. doi: 10.1016/j.ejso.2003.08.007.
10
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.用于预测肝细胞癌根治性切除术后早期复发的术前血清肝酶标志物。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.

引用本文的文献

1
Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System.LI-RADS 形态学类型 II 肝细胞癌早期复发风险评分系统的建立与验证。
J Gastrointest Surg. 2023 Dec;27(12):2787-2796. doi: 10.1007/s11605-023-05873-9. Epub 2023 Nov 6.
2
Robotic liver resection for hepatocellular carcinoma: analysis of surgical margins and clinical outcomes from a western tertiary hepatobiliary center.肝细胞癌的机器人肝切除术:来自西方三级肝胆中心的手术切缘及临床结果分析
J Robot Surg. 2023 Apr;17(2):645-652. doi: 10.1007/s11701-022-01468-9. Epub 2022 Oct 21.
3
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.基于 MRI 影像组学的Nomogram 模型预测 TACE 治疗 HCC 的肿瘤应答情况。
Eur Radiol. 2021 Oct;31(10):7500-7511. doi: 10.1007/s00330-021-07910-0. Epub 2021 Apr 16.
4
Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.使用放射组学列线图预测适合根治性消融的肝细胞癌早期复发。
Cancer Imaging. 2019 Apr 26;19(1):21. doi: 10.1186/s40644-019-0207-7.
5
Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?是否存在一种能够预测肝细胞癌预后的最佳分期系统或肝脏储备模型?
J Gastrointest Oncol. 2018 Aug;9(4):750-761. doi: 10.21037/jgo.2018.05.11.
6
Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection.米兰标准内肝细胞癌根治性切除术后早期复发的预测
Oncotarget. 2017 Jun 28;8(38):63299-63310. doi: 10.18632/oncotarget.18799. eCollection 2017 Sep 8.
7
Prognostic impact of surgical margin in patients with hepatocellular carcinoma: A meta-analysis.手术切缘对肝细胞癌患者的预后影响:一项荟萃分析。
Medicine (Baltimore). 2017 Sep;96(37):e8043. doi: 10.1097/MD.0000000000008043.
8
Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.乙型肝炎相关肝细胞癌复发的危险因素及切除术后独立预测评分
PLoS One. 2016 Feb 22;11(2):e0148493. doi: 10.1371/journal.pone.0148493. eCollection 2016.
9
Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.用于评估接受根治性肝切除的肝细胞癌患者生存情况的SSCLIP评分系统的建立与验证
PLoS One. 2015 Jun 9;10(6):e0129000. doi: 10.1371/journal.pone.0129000. eCollection 2015.
10
Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.基于肝脏硬度值的肝细胞癌根治性切除术后晚期复发风险评估:预测模型的建立与验证
PLoS One. 2014 Jun 9;9(6):e99167. doi: 10.1371/journal.pone.0099167. eCollection 2014.

本文引用的文献

1
Liver resection for cancer.肝癌肝切除术
World J Gastroenterol. 2001 Dec;7(6):766-71. doi: 10.3748/wjg.v7.i6.766.
2
Hepatocellular carcinoma--cause, treatment and metastasis.肝细胞癌——病因、治疗与转移
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.
3
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.101例肝细胞癌患者队列的临床特征与转归
World J Gastroenterol. 2001 Apr;7(2):208-15. doi: 10.3748/wjg.v7.i2.208.
4
Progress in research of liver surgery in China.中国肝脏外科研究进展。
World J Gastroenterol. 2000 Dec;6(6):773-776. doi: 10.3748/wjg.v6.i6.773.
5
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.宋卡王子大学医学院素叻他尼医院336例肝细胞癌患者的回顾。
World J Gastroenterol. 2000 Jun;6(3):339-343. doi: 10.3748/wjg.v6.i3.339.
6
Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy.肝癌的复发或转移:预测因素、早期检测及实验性抗血管生成治疗
World J Gastroenterol. 2000 Feb;6(1):61-65. doi: 10.3748/wjg.v6.i1.61.
7
Potential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks.肿瘤抑制基因和微卫星不稳定性在南部非洲黑人肝细胞癌发生中的潜在作用。
World J Gastroenterol. 2000 Feb;6(1):37-41. doi: 10.3748/wjg.v6.i1.37.
8
Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department.悉尼市中心的肝细胞癌:肿瘤内科10年病例回顾
World J Gastroenterol. 1999 Dec;5(6):483-487. doi: 10.3748/wjg.v5.i6.483.
9
Prospect of gastroenterology and hepatology in the next century.下一世纪胃肠病学与肝病学的展望。
World J Gastroenterol. 1999 Jun;5(3):185-190. doi: 10.3748/wjg.v5.i3.185.
10
Clinical research advances in primary liver cancer.原发性肝癌的临床研究进展
World J Gastroenterol. 1998 Dec;4(6):471-474. doi: 10.3748/wjg.v4.i6.471.

利用CLIP评分预测肝细胞癌患者切除术后的复发及预后

Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

作者信息

Zhao Wen-He, Ma Zhi-Min, Zhou Xing-Ren, Feng Yi-Zheng, Fang Bao-Shan

机构信息

Department of Oncosurgery, the First Affiliated Hospital, Zhejiang University, Medical College, 79 Qingchun, Hangzhou 310003, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2002 Apr;8(2):237-42. doi: 10.3748/wjg.v8.i2.237.

DOI:10.3748/wjg.v8.i2.237
PMID:11925599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4658358/
Abstract

AIM

The survival time of patients with hepatocellular carcinoma (HCC) after resection is hard to predict. Both residual liver function and tumor extension factors should be considered. A new scoring system has recently been proposed by the Cancer of the Liver Italian Program (CLIP). CLIP score was confirmed to be one of the best ways to stage patients with HCC. To our knowledge, however, the literature concerning the correlation between CLIP score and prognosis for patients with HCC after resection was not published. The aim of this study is to evaluate the recurrence and prognostic value of CLIP score for the patients with HCC after resection.

METHODS

A retrospective survey was carried out in 174 patients undergoing resection of HCC from January 1986 to June 1998. Six patients who died in the hospital after operation and 11 patients with the recurrence of the disease were excluded at 1 month after hepatectomy. By the end of June 2001, 4 patients were lost and 153 patients with curative resection have been followed up for at least three years. Among 153 patients, 115 developed intrahepatic recurrence and 10 developed extrahepatic recurrence, whereas the other 28 remained free of recurrence. Recurrences were classified into early (< or =3 year) and late (>3 year) recurrence. The CLIP score included the parameters involved in the Child-Pugh stage (0-2), plus macroscopic tumor morphology (0-2), AFP levels (0-1), and the presence or absence of portal thrombosis (0-1). By contrast, portal vein thrombosis was defined as the presence of tumor emboli within vascular channel analyzed by microscopic examination in this study. Risk factors for recurrence and prognostic factors for survival in each group were analyzed by the chi-square test, the Kaplan-Meier estimation and the COX proportional hazards model respectively.

RESULTS

The 1-, 3-, 5-, 7-,and 10-year disease-free survival rates after curative resection of HCC were 57.2%, 28.3%, 23.5%, 18.8%, and 17.8%, respectively. Median survival time was 28, 10, 4, and 5 mo for CLIP score 0, 1, 2, 3, and 4 to 5, respectively. Early and late recurrence developed in 109 patients and 16 patients respectively. By the chi-square test, tumor size, microsatellite, venous invasion, tumor type (uninodular, multinodular, massive), tumor extension (< or = or >50% of liver parenchyma replaced by tumor), TNM stage, CLIP score, and resection margin were the risk factors for early recurrence, whereas CLIP score and Child-Pugh stage were significant risk factors for late recurrence. In univariate survival analysis, Child-Pugh stages, resection margin, tumor size, microsatellite, venous invasion, tumor type, tumor extension, TNM stages, and CLIP score were associated with prognosis. The multivariate analysis by COX proportional hazards model showed that the independent predictive factors of survival were resection margins and TNM stages.

CONCLUSION

CLIP score has displayed a unique superiority in predicting the tumor early and late recurrence and prognosis in the patients with HCC after resection.

摘要

目的

肝细胞癌(HCC)患者切除术后的生存时间难以预测。残余肝功能和肿瘤扩展因素均应予以考虑。意大利肝癌研究组(CLIP)最近提出了一种新的评分系统。CLIP评分已被证实是对HCC患者进行分期的最佳方法之一。然而,据我们所知,关于CLIP评分与HCC切除术后患者预后相关性的文献尚未发表。本研究的目的是评估CLIP评分对HCC切除术后患者的复发及预后价值。

方法

对1986年1月至1998年6月期间接受HCC切除术的174例患者进行回顾性调查。6例术后死于医院的患者以及11例术后1个月疾病复发的患者被排除。至2001年6月底,4例失访,153例根治性切除患者至少随访了3年。153例患者中,115例发生肝内复发,10例发生肝外复发,其余28例无复发。复发分为早期(≤3年)和晚期(>3年)复发。CLIP评分包括Child-Pugh分期(0 - 2)所涉及的参数,加上宏观肿瘤形态(0 - 2)、甲胎蛋白水平(0 - 1)以及门静脉血栓形成情况(0 - 1)。相比之下,本研究中门静脉血栓形成定义为通过显微镜检查在血管通道内存在肿瘤栓子。分别采用卡方检验、Kaplan-Meier估计法和COX比例风险模型分析每组患者复发的危险因素及生存的预后因素。

结果

HCC根治性切除术后1年、3年、5年、7年和10年的无病生存率分别为57.2%、28.3%、23.5%、18.8%和17.8%。CLIP评分为0、1、2、3以及4至5时,中位生存时间分别为28个月、10个月、4个月和5个月。早期和晚期复发分别发生在109例和16例患者中。通过卡方检验,肿瘤大小、微小卫星灶、静脉侵犯、肿瘤类型(单结节、多结节、巨块型)、肿瘤扩展(≤或>肝实质的50%被肿瘤取代)、TNM分期、CLIP评分和手术切缘是早期复发的危险因素,而CLIP评分和Child-Pugh分期是晚期复发的显著危险因素。在单因素生存分析中,Child-Pugh分期、手术切缘、肿瘤大小、微小卫星灶、静脉侵犯、肿瘤类型、肿瘤扩展、TNM分期和CLIP评分与预后相关。COX比例风险模型的多因素分析显示,生存的独立预测因素是手术切缘和TNM分期。

结论

CLIP评分在预测HCC切除术后患者肿瘤的早期和晚期复发及预后方面显示出独特的优势。